In addition, ocular gene therapy for inherited retinal degeneration is showing benefit in early clinical trials. [1–3] Stimuli-responsive NPs may also act as biosensors in the intraocular milieu.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback